Ignite Creation Date:
2024-05-06 @ 2:11 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04245670
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-09-28
First Post:
2020-01-27
Brief Title:
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost
Sponsor:
Sunnybrook Health Sciences Centre
Organization:
Sunnybrook Health Sciences Centre
Study Overview
Official Title:
5 Fractions of Pelvic SABR With Intra Prostatic SABR BoostA Phase II Study 5STAR-PC
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2022-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
5STAR-PC
Brief Summary:
Stereotactic Ablative Body Radiotherapy SABR given in 5 weekly fractions Simultaneously treating the pelvic lymph nodes prostate and MRI-nodule to a total dose of 25 Gy 35 Gy and up to 50 Gy respectively The radiation will be given with 6-18 months of ADT
5-fraction SABR is a feasible well-tolerated effective and cost effective treatment for high-intermediate and high risk prostate cancer withwithout an image-guided intraprostatic boost
5-fraction SABR is a feasible well-tolerated effective and cost effective treatment for high-intermediate and high risk prostate cancer withwithout an image-guided intraprostatic boost
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None